These findings also confirmed that the knockdown of the IFITM3 expression effectively inhibited the growth process of the AML bearing mice in our experiment, and this approach may provide a the translational potential in clinical AML treatment. The gene discussed is IFITM3; the disease is acute myeloid leukemia.